Abhay H Pande

16PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCheminformatics and quantitative structure-activity relationshipsNutrigenomics and personalised nutritionGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 15, 2026
Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy.

Sandeep, Suraj H Shinde, Sakeel Ahmed

|Dec 18, 2025
Radioligand-Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis.

Prakash Y Khandave, Pravin U Gudavalekar, Tapas Das

|Oct 22, 2025
Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions.

Abhishek K Tiwatane, Prakash Y Khandave, Sampada Sharad Kulkarni

|Oct 05, 2025
Challenges and advances in the development of antidotes against A-series nerve agents.

Rajan K Tripathy, Khushi Goyal, Prakash Y Khandave

|May 19, 2025
Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations.

Abhay H Pande, Yenisetti Rajendra Prasad, J Anakha

|Feb 14, 2025
Nanobody-Oligonucleotide Conjugates (NucleoBodies): The Next Frontier in Oligonucleotide Therapy.

Rajan K Tripathy, Abhay H Pande

Pageof 3

Frequent Collaborators

3 joint publications

Prakash Y Khandave

2 joint publications

Prakashkumar Dobariya

2 joint publications

J Anakha

1 joint publications

Gopal Patel